Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

Biobanking powerhouse, Brooks Life Sciences, takes ISBER 2018 with a bioBANG

Biobanking powerhouse, Brooks Life Sciences, takes ISBER 2018 with a bioBANG

As Brooks Life Sciences cements its commitment to developments in the biobanking industry that accelerate research and improve patient health – the events at ISBER 2018 in Dallas, TX last week only magnify this dedication.

One of Brooks Life Sciences’ newest innovations, the IntelliXmark™ won the ISBER Outstanding New Product Award. IntelliXmark is an innovative instrument that prints text, linear barcodes, 2D codes, and graphics directly onto plastic sample tubes. It is resistant to alcohol, water, liquid nitrogen, and mechanical abrasion.

Brooks Life Sciences Product Marketing Manager, Mike Thurogood, highlighted that IntelliXmark can eliminate the need for less-reliable labels or marker pens in the lab.

“The IntelliXmark allows clean, simple, durable labelling directly onto plastic sample tubes. So, all that supplementary information such as patient IDs and lot numbers can be printed directly onto the tubes,” he explained. “It creates consistently legible text and barcodes at high resolutions for ease and convenience in the lab.”

Speaking of the place where science evolves – Dr. Andy Brooks, Chief Scientific Officer for Brooks Life Sciences, was honored with the ISBER Special Service Award at the annual meeting.

This distinction is given to those who have made exceptional contributions toward the goals of the society through performance of a special service or act on behalf of the organization. Dr. Brooks’ award is for long-term commitment and promotion of the applied side of biobanking.

As someone who has devoted the better part of his career to advancing science for biological repositories, Dr. Brooks has helped develop many of the standards and SOPs in use today.

“For many years, my work – both scientifically and on the service side – has been to develop quality assurance and quality control technologies to ensure high quality biological specimens that help link all the activities we do with sample collection and sample storage to the analytics, discovery, and clinical activities for use of those samples,” he shared. “So, this award is particularly special, because it’s a recognition of the contribution that my team and I have made for the different kinds of science and technologies we integrate into our service offerings and into our scientific programs.”

ISBER also announced that David Lewandowski with Brooks Life Sciences will assume the role of president for ISBER (International Society for Biological and Environmental Repositories).

In his new role, Lewandowski will carry on best practices of the global biobanking organization as it creates opportunities for networking, education, and innovations – and harmonizes approaches to evolving challenges in biological and environmental repositories.

“I’m very humbled to have been elected ISBER president for 2018-2019. I look forward to working with the many volunteers who have made this society what it is,” said Lewandowski.

“In this next year,” he continued, “I think we’re going to be really focused on highlighting all those breakthroughs in biobanking and successes everyone has experienced. And we’ll be sharing those stories next year as we celebrate ISBER’s 20th anniversary in Shanghai, China.”

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post